236 related articles for article (PubMed ID: 32576072)
1. Trimethylamine-
Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
[No Abstract] [Full Text] [Related]
2. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
[TBL] [Abstract][Full Text] [Related]
3. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
4. Association of trimethylamine
Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
[TBL] [Abstract][Full Text] [Related]
5. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
6. Trimethylamine
Stubbs JR; Stedman MR; Liu S; Long J; Franchetti Y; West RE; Prokopienko AJ; Mahnken JD; Chertow GM; Nolin TD
Clin J Am Soc Nephrol; 2019 Feb; 14(2):261-267. PubMed ID: 30665924
[TBL] [Abstract][Full Text] [Related]
7. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
9. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
11. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
13. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
14. Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study.
Borges NA; Stenvinkel P; Bergman P; Qureshi AR; Lindholm B; Moraes C; Stockler-Pinto MB; Mafra D
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):648-654. PubMed ID: 29651635
[TBL] [Abstract][Full Text] [Related]
15. The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease.
Tomlinson JAP; Wheeler DC
Kidney Int; 2017 Oct; 92(4):809-815. PubMed ID: 28807612
[TBL] [Abstract][Full Text] [Related]
16. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients.
Shafi T; Powe NR; Meyer TW; Hwang S; Hai X; Melamed ML; Banerjee T; Coresh J; Hostetter TH
J Am Soc Nephrol; 2017 Jan; 28(1):321-331. PubMed ID: 27436853
[TBL] [Abstract][Full Text] [Related]
17. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
18. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
[TBL] [Abstract][Full Text] [Related]
19. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
20. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
Fukami K; Yamagishi S; Sakai K; Kaida Y; Yokoro M; Ueda S; Wada Y; Takeuchi M; Shimizu M; Yamazaki H; Okuda S
J Cardiovasc Pharmacol; 2015 Mar; 65(3):289-95. PubMed ID: 25636076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]